National Museums Scotland has announced the acquisition of an ornate early 18th-century sundial of exceptional precision and design. The Ilay Glynne dial, which is now on display at the National Museum of Scotland in Edinburgh, is a masterpiece of both art and science.
The Ilay Glynne dial, made around 1715, was used to measure local time from the Sun, providing the most accurate means of setting clocks available at the time. It could be used at any latitude, and its form models the celestial sphere, showing the Sun’s apparent motion around the Earth.
The acquisition of the dial, which has important connections to post-Union Scotland, has been supported by the National Heritage Memorial Fund and Art Fund.
The dial was commissioned by and belonged to Archibald Campbell, Earl of Ilay and later 3rd Duke of Argyll (1682-1761).
Ilay was hugely influential figure in post-Union Scotland. He had control over royal patronage in Scotland, and managed Scottish affairs, making him the most politically powerful figure in the first half of the 18th century.
He was a founder and the first governor of the Royal Bank of Scotland. His likeness used to appear on all RBS banknotes, and still appears on the £100 note today. Through his patronage, including at Scottish universities, he became an important sponsor and promoter of the culture of the Scottish Enlightenment
It is signed by Richard Glynne (1681-1755), a successful and well-regarded maker of mathematical instruments and a member of the Clockmakers’ Company. In his business, skills and innovations, Glynne was closely integrated with a growing community of British instrument makers and produced instruments of outstanding quality, of which this dial is the most important surviving example.
The dial is of a type first made for figures such as Peter I of Russia and Queen Anne’s consort, Prince George of Denmark, suggesting Ilay commissioned it from Glynne as a projection of his reputation as a nobleman of wealth and status.
Of imposing size, in brass and silvered brass, it is surmounted with the Ilay coat of arms, with leopard supporters, coronet and motto, and the central plate is decorated with the monogram ‘AC’, for Archibald Campbell, beneath an earl’s coronet.
Dr Rebekah Higgitt, Principal Curator of Science at National Museums Scotland, said: “We’re delighted to be able to acquire the spectacular Ilay Glynne dial and hugely grateful to the funders who have made it possible.
“It is an addition which reflects the breadth of our collections, being at once a significant scientific instrument, an object of great beauty and one with strong connections to key developments in Scotland’s history.”
Dr Simon Thurley, Chair of the National Heritage Memorial Fund, said: ”The Ilay-Glynne dial is a magnificent example of scientific endeavour, and we are delighted to have supported National Museums Scotland to acquire it for a UK public collection.
“Not only is it an exquisite instrument, but its provenance offers an opportunity to explore important stories about scientific, intellectual and cultural currents that saw the birth of the Scottish Enlightenment.”
Jenny Waldman, Director, Art Fund said: “This stunning sundial offers a unique insight into scientific innovations in 18th century Scotland. The precision and detail of the craftsmanship is exquisite, a true work of art.
“I’m so pleased that Art Fund has been able to support National Museums Scotland to acquire this remarkable object for their permanent collection, ensuring it will continue to enlighten visitors from Scotland and beyond on public display in the Spirit of the Age gallery.”
The Ilay Glynne dial reveals the Earl of Ilay not just as the politically powerful and wealthy figure he is best known as, but also as a patron of arts, science and learning. It is through this patronage that Ilay is widely believed to have contributed to the Scottish Enlightenment.
Those he supported include philosopher Francis Hutcheson, chemist Joseph Black, astronomer Alexander Wilson, poet Allan Ramsay and other ingenious individuals who created emblematic works of 18th-century Scottish culture.
In Scotland, Ilay pursued agricultural and infrastructure projects, the development of fisheries and promotion of the linen trade. As founder and governor of the Royal Bank of Scotland and the British Linen Company he aimed to encourage others to invest and improve.
Some of these investments were in overseas trading companies, such as the African Company, East India Company and South Seas Company, which profited from colonisation and the exploitation of enslaved people, an important reminder of a key source of wealth that underlay economic and cultural change in 18th-century Scotland.
The dial has undergone extensive cleaning and conservation work, and is now on permanent display in the Spirit of the Age gallery in the National Museum of Scotland. Admission is free.
Two unique Jurassic fossil discoveries from the Isle of Skye have shown that mammals in the time of the dinosaurs grew more slowly and lived longer than mammals today.
A new study in Nature by an international team of researchers led by National Museums Scotland describes two Krusatodon kirtlingtonensis fossils, one adult and one juvenile, both discovered in Skye.
These mouse-sized mammals lived around 166 million years ago. The specimens represent the only juvenile Jurassic mammal skeleton known to science, while the adult is one of the most intact mammal skeletons from this time period in the world.
The discovery of a juvenile and adult of the same species of early mammals is unique and has allowed groundbreaking comparative analysis into their growth and life history. The ages of the specimens at death were determined using X-ray imaging to count the growth rings in their teeth.
The adult was found to be around 7 years old and the juvenile between 1 – 2 years, and still in the process of replacing its baby teeth. This was possible thanks to X-ray computed tomography carried out in several laboratories, including the European Synchrotron (ESRF).
Today, small mammals have significantly shorter lifespans, some living as little as 12 months, and maturing quickly, losing their baby teeth and weaning within months of birth. The Krusatodon fossils reveal for the first time that the earliest mammals didn’t finish replacing their teeth until well into their second year of life, possibly later. This tells us that a fundamental shift in the growth patterns and life expectancy of mammals must have taken place during or after the Middle Jurassic.
The specimens were discovered decades apart, with the adult being one of the earliest Jurassic finds on Skye in the 1970s, while the juvenile was discovered in 2016.
Dr Elsa Panciroli, lead author and Associate Researcher of Palaeobiology at National Museums Scotland, said: “These fossils are among the most complete mammals from this time period in the world. They give us unprecedented insights into the lives of the first mammals in the time of dinosaurs.
“Although on the outside Krusatodon looked like a shrew or mouse, on the inside it was quite different; it grew more slowly and lived much longer than small mammals do today. As a result, it probably had quite a different physiology and life history as well. Skye’s fossils are really putting Scotland firmly on the map when it comes to understanding mammal evolution.
“This is just the tip of the iceberg in terms of what they can tell us.”
Dr Stig Walsh, Senior Curator of Vertebrate Palaeobiology at National Museums Scotland and co-author on the study, said: “Even in the context of the amazing palaeontological finds on Skye in recent years, these fossils are remarkable.
“Mammal fossils of this age are exceptionally rare worldwide, and most are just single teeth found by sieving sediment. To find two such rare fossil skeletons of the same species at different growth stages has rewritten our understanding of the lives of the very earliest mammals.
“We’re thrilled they are both now part of Scotland’s National Collection, an important part of the global fossil record, and will be preserved for generations of researchers to come.”
In addition to National Museums Scotland, the study also involved researchers from the American Museum of Natural History, University of Chicago, European Synchrotron Radiation Facility, and Queen Mary University of London.
Prof. Roger Benson from the American Museum of Natural History said of the fossil found in 2016: “When we found the tiny juvenile skull I didn’t realise what we’d found right away.
“The part of the fossil that was sticking out of the rock was blasted by erosion, surrounded by barnacles, and looked just like a piece of ash. I used micro-CT scanning, a form of 3D X-ray imaging, and was very surprised to see a whole skull in the rock. For science,
“it’s really remarkable to have this fossil and it told us a lot about growth and life history in some of the earliest mammals”
Dr Elis Newham, a Postdoctoral Research Associate at Queen Mary University of London said: “Our study benefited greatly from a new technique we developed using synchrotron X-ray technology.
“This allowed us to analyse growth patterns in the teeth of these fossils, much like counting tree rings. It was surprising to discover that Krusatodon, while showing a similar development pattern to modern mammals, grew much slower and lived longer.
“This research emphasises the value of studying juvenile fossils, and the X-ray cementochronology technique offers a powerful tool for unlocking these secrets from the past.”
The paper was published in Nature yesterday, 24 July 2024.
The projects come from the National Space Innovation Programme (NSIP) – designed to invest in high-potential technologies and drive innovation and growth
Five projects funded by the UK Space Agency across Scotland have been announced on the opening day of the Farnborough International Airshow, providing over £10.5 million in Scottish investment.
The projects come from the National Space Innovation Programme (NSIP) – designed to invest in high-potential technologies and drive innovation and growth in the space sector across the UK.
Two Scottish projects will receive £8.5 million of the total funding for UK Major Projects. These include funding for a sub-orbital rocket test by HyImpulse (Glasgow) from SaxaVord spaceport in Shetland.
A project led by Spire Global (Glasgow) will further develop technology to supply unique weather forecasting data to global numerical weather prediction centres.
Not only will the funding support the growth of UK space businesses and create new jobs, but it will enhance Scotland’s offering of space capabilities and services to international investors and major space players.
An additional three ‘Kick Starter’ projects across Scotland will receive £2.4million between them. These projects are designed to support technologies and applications that are in an earlier stage of development and increase their readiness for use in commercial and scientific endeavours.
These projects include a partnership between University of Strathclyde, UK Atomic Energy Authority and SJE Space, for a feasibility study into whether terrestrial directed energy drilling (plasmas/microwaves) could be adapted for space applications, specifically lunar exploration.
Speaking at the Farnborough International Airshow where he met with a number of Scottish exhibitors, Scottish Secretary Ian Murray said: “This is an exciting time for the Scottish space sector as we look forward to the first satellite launch from SaxaVord in Shetland later this year.
“The burgeoning industry plays a vital role in our economy and employs thousands of people across the country. It was fantastic to meet with some of them here and hear about their pioneering plans which could be a key driver for growth, jobs and investment in Scotland.
“Scotland is a major player in the international space industry and I am delighted the UK Government is continuing to back the sector with £10.9 million in funding for these five Scottish projects.”
Dr Paul Bate, CEO of the UK Space Agency, said: “These new projects will help kickstart growth, create more high-quality jobs, protect our planet and preserve the space environment for future generations.
“They go to the heart of what we want to achieve as a national space agency that supports cutting-edge innovation, spreads opportunity across the UK and delivers the benefits of space back to citizens on Earth.”
Chair of the UKspace trade association, John Hanley, said: “This investment into the space industry demonstrates the importance of funding through a national programme to unlock innovative collaborations in all parts of the UK.
“We hope this will further strengthen the sector and build upon the growth we have seen in recent years.”
This project will set out to conduct a vertical launch of a sounding rocket in the UK with the final goal being the build completion of the second stage of the orbital rocket ready for testing. HyImpulse, in partnership with Cranfield University, Birmingham University and the AVICON Partnership, intends to provide a fully vertically integrated launch service for a low-cost, fast, flexible, and reliable deployment of small satellites to low earth orbits.
Led by Spire Global in partnership with STAR-Dundee Ltd, the Met Office and RAL Space (UKRI STFC), this project will build on the prior developments of the Hyperspectral Microwave Sounder (HYMS) to move it towards an operational mission to supply weather forecasting data to global numerical weather prediction (NWP) centres and create unique weather products.
Kick Starter Projects
DIGGER – Drilling and Integrated GigaHertz-Generated Energy Resource for Lunar and Asteroid applications
Funding: £845,000
In partnership with University of Strathclyde, UK Atomic Energy Authority and SJE Space, DIGGER is a feasibility study into whether terrestrial directed energy drilling (plasmas/microwaves) could be adapted for space applications, specifically lunar exploration.
Direct Detection Receivers for Millimetre Wave Radiometry
Funding: £827,000
Led by UKRI / STFC / RAL Space in partnership with University of Glasgow and Spire Glasgow, the project will develop the critical low noise amplifier and detector technology which will be at the core of the next generation of atmospheric remote sensing instrumentation. This technology will go beyond gathering data for weather prediction, with use cases being developed in emerging fields such as security imaging, and theft prevention.
TARS-IOD: Flight-ready model for In-Orbit Demonstration of Tomorrow’s Astro-Robotic System
Funding: £804,000
Lodestar Space Ltd. will develop a platform-agnostic modular robotic arm to perform contact dependent dynamic space operations. Intended for flight on Momentus’ Vigoride platform, the partnership also involves Growbotics and the University of Glasgow to equip the UK with sovereign capabilities for inspecting, protecting, and repairing vital assets beyond Earth.
An environmental scientists and former broadcaster has been recognised as part of University of the West of Scotland’s (UWS) graduations.
Dr Hermione Cockburn, who was awarded an OBE in 2020 for services to public engagement in science, was celebrated as part of a ceremony taking place at Paisley Abbey last week (Wednesday 3 July).
Dr Cockburn began her career at the University of Edinburgh researching landscape change in Africa and Antarctica. She then completed a post doctorate at the University of Melbourne.
For the past 20 years, she has worked exclusively in science communication and presented television series like Coast, Rough Science, Fossil Detectives: Discovering Prehistoric Britain and The Nature of Britain for the BBC.
She has also presented Radio 4 documentaries on subjects ranging from lead pollution to lasers, as well as an award-winning series on bacteria.
Dr Cockburn taught environmental science for the Open University for many years and is passionate about life-long learning. Her most recent role as the Scientific Director at Dynamic Earth in Edinburgh saw her lead the charity’s mission that focuses on empowering people with understanding and empathy for the planet.
Recently, she led a major ocean literacy project about Scotland’s deep sea, collaborating closely with marine scientists from across the UK. She is a Trustee of the Association of Science and Discovery Centres, a fellow of The Royal Society of Edinburgh, and an honorary fellow of the Royal Scottish Geographical Society.
Professor Andrew Hursthouse delivered Dr Cockburn’s laureation speech, which touched on her inspirational career to date.
Discussing her Honorary Doctorate from UWS, Dr Cockburn said, “It’s an honour to receive this Honorary Doctorate.
“As someone who is passionate about science education and life-long learning, it’s been inspiring to be a part of the ceremony today and see so many graduates take the next step in that journey.”
Professor James Miller, Principal and Vice-Chancellor of UWS, said: “Graduation is the pinnacle of the University calendar. It gives us the opportunity to both reflect on the amazing achievements of our students and to celebrate this most important of milestones with their friends and families, as well as the whole UWS community who have supported them throughout their time at university.
“We are delighted to present Dr Hermione Cockburn with this Honorary Doctorate. We know she will be a role model not only to students studying scientific disciplines but also those who are keen to work in science engagement. Her commitment to encouraging life-long learning and environmental awareness is aligned to our own values here at the University.”
Thales Alenia Space, a joint-venture between Thales (67%) and Leonardo (33%), harness students’ curiosity for space, science and life on Mars with the launch of MARSBalloon 2024.
Led by Thales Alenia Space graduates and apprentices in the UK, MARSBalloon is a hands-on science project for primary and secondary students and shows how exciting and varied career opportunities in space, engineering and science can be – without putting on a space suit.
Students work together to create experiments to test the response of electronics, materials, plants and even food to the harsh conditions in space.
Experiments fit inside a small capsule and fly on the high altitude balloon, rising to an altitude of 30km, more than twice the height of commercial airliners where conditions are very similar to the surface of Mars – including temperatures of -50°C and pressures 1/100th that of sea level.
This year’s MARSBalloon will also have a competitive element, with prizes awarded for primary and secondary categories for Best Innovation, Best Decoration, Engineers Choice and VIP Judge’s Choice award.
The deadline for registration is 8th March 2024 with the launch of the balloon in May.
8th March: Last day for Registration. The process take five minutes and can be done here.
30th April: Deadline for experiment delivery to Thales Alenia Space
May / June: MARSBalloon launch (depending on weather conditions)
Ballymacash Primary school has already signed up. Primary teacher, Susan Brown, said: “We are so excited to be involved in such an amazing activity. The students can’t wait to start dreaming up their own experiments.
“We’re looking forward to having our very own MARSBalloon workshop in March – so watch this space to see what the children come up with!”
Drashti Shah, Thales Alenia Space Engineer and MARSBalloon Project Manager, said: “We are delighted to have launched MARSBalloon 2024. We had a record number of participants last year, flying over 200 experiments into the stratosphere, and this year we have changed the dates to allow more schools to get involved. I
“t is a fantastic fun, free of charge that really gives young student experience of deigning their own experiments and first-hand experience learning more about space, widening their future career horizons”
Drawing on over 40 years of experience and a unique combination of skills, expertise and cultures, Thales Alenia Space delivers cost-effective solutions for telecommunications, navigation, Earth observation, environmental management, exploration, science and orbital infrastructures.
Governments and private industry alike count on Thales Alenia Space to design satellite-based systems that provide anytime, anywhere connections and positioning, monitor our planet, enhance management of its resources, and explore our Solar System and beyond. Thales Alenia Space sees space as a new horizon, helping to build a better, more sustainable life on Earth.
A joint venture between Thales (67%) and Leonardo (33%), Thales Alenia Space also teams up with Telespazio to form the parent companies’ Space Alliance, which offers a complete range of services. Thales Alenia Space posted consolidated revenues of approximately 2.2 billion euros in 2022 and has around 8,500 employees in 10 countries with 17 sites in Europe and a plant in the US.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Countless lives could be saved thanks to a multi-million pound UK government investment in potential breakthrough medical devices.
As part of a £10 million funding package for boosting access to medical technology, eight innovative tech companies will be supported to bring their devices to market. It could help transform the way we treat some of the biggest causes of death and disability in the UK.
One device, by HistoSonics, aims to identify and destroy liver cancer tumours using focused ultrasound waves. These waves break down tumours without damaging healthy tissue, offering a safer alternative to radiotherapy and other high intensity treatments. It could improve quality of life for many patients going through treatment – reducing hospital visits, post procedure complications, and making pain management easier.
Today’s announcement is part of the government’s long-term plan to ensure the NHS and its patients can get quicker access to new ‘groundbreaking’ technologies. It follows the unveiling of our groundbreaking blueprint for boosting NHS medtech and turning innovation into real benefits for society last year.
Health Minister Andrew Stephenson said: “NHS staff need access to the latest technology to deliver the highest quality care for patients and cut waiting lists – one of our top five priorities.
“These cutting-edge technologies could help thousands of patients with a range of conditions, including cancer, stroke, and Alzheimer’s, while easing pressure on our hospitals and reducing healthcare inequalities.
“Our investment in these pioneering companies is part of our long-term plan for a faster, simpler and fairer health care system, and demonstrates our clear commitment to ensuring the UK is the most innovative economy in the world.”
One company is developing a blood test for Alzheimer’s Disease which means patients could be identified and treated earlier. Roche Diagnostics Ltd has developed the Amyloid Plasma Panel – a blood test which could help clinicians decide if patients with cognitive impairment should undergo tests or imaging to confirm Alzheimer’s Disease.
A portable blood test, from Upfront Diagnostics, could help paramedics identify stroke patients more quickly. Currently, ambulance workers can’t recognise a patient with a blood clot blocking the flow of blood and oxygen to their brain, who would require urgent treatment at stroke centres rather than local hospitals.
The blood test could help them recognise these cases on the spot – so patients could be taken to a comprehensive stroke centre for immediate, vital treatment. It could mean thousands are spared long-term disability and the associated care costs, while reducing pressure on A&E departments nationwide.
Dr Marc Bailey, Medicines and Healthcare products Regulatory Agency Chief Science and Innovation Officer, said: “We are very excited to announce the final eight selected technologies in the new IDAP pilot scheme.
“This is designed to explore how support from the regulator, UK health technology organisations and NHS bodies can accelerate the development of transformative medical devices from their initial proof of concept through to uptake in the NHS.
“The pilot criteria prioritises patient need in all aspects of decision-making and, by supporting innovative medical technologies, will ease pressure on the healthcare system. Most important, it’s an initiative which could be life-changing for many patients.
“We are committed to being a regulator that establishes the UK as a centre of medical innovation and look forward to working with the wider healthcare system to achieve this.”
The funding is part of a radical new programme called The Innovative Devices Access Pathway (IDAP), which aims to bring state-of-the-art technologies and solutions to the forefront of the NHS. Currently in the pilot stage, the funding will be used to test the new technologies for use on a large scale as quickly as possible.
The government is investing £10 million in the pilot as part of a wider programme of work to accelerate access to medical technology.
The programme is run by the Medicines and Healthcare products Regulatory Agency (MHRA), The National Institute for Health and Care Excellence (NICE), NHS England, Health Technology Wales, and Scottish Health Technology Group. They will be providing tailored, intensive advice on regulatory approval, health tech assessments and access to the NHS.
Jeanette Kusel, Director of NICE Advice (The National Institute for Health and Care Excellence) said: “NICE’s ambition is to drive innovation into the hands of health and care professionals to enable best practice in health and care treatment.
“Through IDAP and our support service NICE Advice, we aim to be a trusted adviser, providing tailored advice and supporting businesses along the whole product lifecycle helping them realise their ambition and helping bring the very best of innovation into the NHS and the hands of patients.”
Lenus Health Ltd. is using artificial intelligence to predict patients at risk of hospitalisation for Chronic Obstructive Pulmonary Disease, which causes the airways to become narrow and damaged, resulting in breathing difficulties.
The company collects data from wearable devices, sensors and apps and uses AI to predict which patients are at greater risk of hospital admissions. This allows them to be monitored and treated more effectively, while simultaneously reducing pressure on hospitals.
Another device aims to reduce inequalities in the field of lung health. Oximeters – devices clipped over the end of a fingertip – are used widely at hospitals and at home to assess how well the lungs and circulatory system are working. However, research suggests this technology may not accurately detect falling oxygen levels in people with darker skin tones.
EarSwitch has produced a device which detects oxygen levels from the inner ear-canal instead, which is not pigmented irrespective of the person’s skin colour. It could offer better quality readings and a more innovative approach to oxygen level monitoring.
Vin Diwakar, Interim National Director of Transformation, NHS England, said: “This is an important milestone in our work to ensure the NHS continues to get the best new technologies and treatments to patients faster, having already rolled out more than 100 new treatments through the cancer drug fund and setting up a dedicated programme to prepare for new Alzheimer’s treatments once they are approved.
“We will be working closely with our partners to support those companies selected for the pilot so that more game-changing, life-saving technologies are introduced quickly and safely on the NHS.”
Other technologies set to benefit from a share of the funding include:
Multiple Sclerosis fatigue app: Avegen Ltd. has developed a new smartphone app that delivers exercises, cognitive behaviour therapy and targeted physical activity in a personally customisable format to help patients manage Multiple Sclerosis (MS).
Self-test for neutropenia: 52 North Health. has developed a new device to allow chemotherapy patients to self-test at home – using a finger-prick blood test – for neutropenic sepsis. This is a life-threatening condition in patients whose immune system is suppressed.
Algorithm infection predictor: Systemic Inflammatory Response Syndrome (SIRS) is a life-threatening medical condition caused by the body’s overwhelming response to infection or inflammation. Presymptom Health Ltd. has developed a new test and algorithm with the potential to predict infection status up to three days before conventional diagnosis is possible.
Dr Susan Myles, Director of Health Technology Wales, said: “Health Technology Wales is proud to have played a role in the selection of eight pilot IDAP technologies which have the potential to support clinicians and improve the lives of patients across the UK.
“We look forward to continuing to support the adoption of innovative health technologies by the NHS.”
In a major report today Westminster’s Science, Innovation & Technology Committee calls for steps to develop the potential of bacteria-killing viruses – called bacteriophages or phages for short – that can provide an alternative to antibiotics that are attracting growing resistance.
Phages have been used as therapy for over a hundred years, but interest has increased in recent years as the widespread use of antibiotics is leading to alarming antimicrobial resistance (AMR) to even the most effective treatments. But they have never been licensed for therapeutic use in the UK. They have only been used as “compassionate” treatments of last resort in isolated cases of otherwise intractable infections.
One of the problems has been an impasse: in order to be deployed in clinical trials phages must be manufactured to the Good Manufacturing Practices (GMP) standard – but investment in compliant manufacturing plants will only be justified following successful clinical trials.
Rt Hon Greg Clark MP, Chair of the Committee, said: “Phages offer a possible response to the increasing worldwide concerns about antimicrobial resistance.
“But the development of phage therapies is at an impasse, in which clinical trials need new advanced manufacturing plants, but investment requires clinical trails to have demonstrated efficacy.
“The Committee is asking the Government to consider whether the mothballed Rosalind Franklin Laboratory in the West Midlands could provide a suitable facility.
“The Laboratory, which has already received over £1 billion of public funding, was established by the Government to bring to an end the inadequacy of testing capacity that so hampered the national response to Covid.
“It consists of modern, secure laboratory facilities and was meant to be an important source of national resilience against future pandemics. But the Rosalind Franklin Laboratory has suddenly appeared for sale on the property website Rightmove, to the astonishment of the science and health communities.
“Our Committee’s report on phages asks for the Rosalind Franklin Laboratory to be considered for this purpose, rather than be lost to the nation and to science in a firesale.”
The Committee recommends that the Government should consider establishing a small GMP facility on the lines of the Catapult network which provides shared facilities for companies who cannot afford to make the level of investment on their own.
The Committee also calls on the Medicines and Healthcare Products Regulatory Agency (MHRA), Department for Health and Social Care (DHSC), and phage researchers to work together to make for a more promising route for phage research to be funded and its products licensed for use.
The Committee calls for:
Awareness-raising for healthcare students and professionals of the antimicrobial potential of phages where antibiotics have failed or are failing
Government and its agencies to make a definitive and positive statement on the role of phages in the national approach to anti-microbial resistance (AMR), which is important in research funding decisions and for private investment in commercial phages
The MHRA to consider allowing the compassionate use of non-GMP phages produced in the UK for last resort medical cases where other medical approaches have failed or are failing
The MHRA to review how current regulations would govern liability for clinicians and hospitals who used UK non-GMP phages,
Healing the Rift: UK to associate to Horizon Europe and Copernicus programmes in new agreement with the EU
UK to associate to Horizon Europe and Copernicus programmes through a bespoke new agreement with the EU.
Prime Minister secured improved financial terms of association that are right for the UK and protect the taxpayer.
British scientists encouraged to apply now for grants and projects with certainty.
UK confirms it will take forward its own fusion energy strategy instead of associating with the Euratom programme.
UK scientists will have access to the world’s largest research collaboration programme, Horizon Europe, as the Prime Minister secures a bespoke deal with improved financial terms for the UK’s participation.
From today (Thursday 7 September), UK researchers can apply for grants and bid to take part in projects under the Horizon programme, with certainty that the UK will be participating as a fully associated member for the remaining life of the programme to 2027.
Once adopted, the UK will also be able to join the governance of EU programmes – which the UK has been excluded from over the last three years – ensuring we can shape collaboration taking place next year. And UK researchers will be able to lead consortia in the next work programme of Horizon Europe projects.
Horizon will give UK companies and research institutions unrivalled opportunities to lead global work to develop new technologies and research projects, in areas from health to AI. This will not only open up cooperation with the EU, but also Norway, New Zealand and Israel which are part of the programme – and countries like Korea and Canada which are looking to join too.
This follows a call between the UK Prime Minister Rishi Sunak and EU Commission President Ursula Von der Leyen yesterday (6 September). They are encouraging UK scientists to apply with confidence from today and they agreed that the UK and EU will work together to boost participation.
As part of the new deal negotiated over the last six months, the Prime Minister has secured improved financial terms of association to Horizon Europe that are right for the UK – increasing the benefits to UK scientists, value for money for the UK taxpayer, and mitigating the impact that the EU’s delays to our association will have on participation rates of researchers.
The UK will also associate to Copernicus, the European Earth Observation programme. This will provide the UK’s earth observation sector with access to unique data – valuable to helping with early flood and fire warnings, for example – and with the ability to bid for contracts, which they haven’t been able to access for three years.
In line with the preferences of the UK fusion sector, the UK has decided to pursue a domestic fusion energy strategy instead of associating to the EU’s Euratom programme. This will involve close international collaboration, including with European partners, and a new, cutting-edge alternative programme, backed by up to £650m to 2027. It will ensure UK taxpayer funding is spent in the UK’s best interests.
Together, this deal is set to create and support thousands of new jobs as part of the next generation of research talent. It will help deliver the Prime Minister’s ambition to grow the economy and cement the UK as a science and technology superpower by 2030.
UK Prime Minister Rishi Sunak said: Innovation has long been the foundation for prosperity in the UK, from the breakthroughs improving healthcare to the technological advances growing our economy.
“With a wealth of expertise and experience to bring to the global stage, we have delivered a deal that enables UK scientists to confidently take part in the world’s largest research collaboration programme – Horizon Europe.
“We have worked with our EU partners to make sure that this is right deal for the UK, unlocking unparalleled research opportunities, and also the right deal for British taxpayers.”
New financial protections for the British taxpayer, especially in the first years of association when UK scientists’ participation will be recovering, ensures:
UK taxpayers will not pay for the time where UK researchers have been excluded from since 2021, with costs starting from January 2024 – delivering much better terms for 2023. This will also provide breathing space to boost the participation of UK researchers in open calls for grants before we start paying into the programme.
The UK will have a new automatic clawback that protects the UK as participation recovers from the effects of the last two and a half years. It means the UK will be compensated should UK scientists receive significantly less money than the UK puts into the programme. This wasn’t the case under the original terms of association.
Secretary of State for Science, Innovation and Technology Michelle Donelan said: “Today is a fantastic day for UK science and our whole economy. We have listened to the sector, and through hard work and negotiation we have secured an excellent deal for researchers, taxpayers and businesses.
“The Horizon programme is unrivalled in its scope and opens up a world of opportunity for cooperation on science that delivers real-world benefits for the UK – creating jobs, boosting our economy and opening up collaboration for the sector with some of our closest partners, whether on tackling climate change or advancing cancer research.
“This deal is a crucial step forward on our mission to become a science and tech superpower by 2030.”
Health and Social Care Committee Chair, Steve Brine MP said: “The announcement that the UK will rejoin the flagship Horizon research programme is of huge importance to the future of cancer research.
“Too much time and work has been lost leaving many in the health and scientific communities angry. They must be profoundly relieved having warned that without access to Horizon, the UK risked losing not only its world-leading reputation on science but access to research upon which crucial work depends.
“Next week we’ll be speaking to renowned specialists in cancer research and questioning them on what impact this major development is likely to have for their work as they seek to revolutionise the diagnosis and treatment of future cancer.”
President of UUK, Professor Dame Sally Mapstone: “The entire research community, within our universities and beyond, will be delighted at the news that an agreement has been reached.Overcoming the obstacles to association was no small feat and we are grateful to the government and the commission for their perseverance to secure this successful outcome.
“Horizon Europe has been the basis of scientific collaboration for over 30 years. From early detection of ovarian cancer to developing clean energy networks involving dozens of universities and many industrial partners, Horizon lets us do things that would not be possible without that scale of collaboration.
“Allowing our scientists to work together, irrespective of borders, is in all of our interests. Our universities will now do everything possible to ensure the UK rapidly bounces back towards previous levels of participation and is able to secure genuine value, delivering the wealth of research opportunities available.”
The Academy of Medical Sciences, the British Academy, the Royal Academy of Engineering, and the Royal Society have issued a joint statement on the UK’s association to Horizon Europe:
‘This is a great day for researchers in the UK and across Europe. The Horizon programme is a beacon of international collaboration and UK-based academic and industrial researchers will now be back at the heart of that.
‘Research is vital to tackling the key problems we face, from global challenges such as climate change to driving productivity growth and creating new jobs locally. Our involvement in Horizon Europe will make the UK stronger and is a big win for global research and innovation.‘
Michelle Mitchell, Chief Executive of Cancer Research UK, said: “Horizon Europe association is overwhelmingly in the best interests of cancer patients and scientists, and it is great news for cancer research that agreement has finally been reached between the UK and EU.
“There will be relief throughout the research community that the uncertainty of the last two and a half years has come to an end. Nearly three quarters of respondents to our survey of cancer researchers cited funding from the EU as important for their work, showing how crucial Horizon Europe association is for the future of cancer research.
“We hope that this deal paves the way for the UK’s ongoing participation in future European research programmes. It is essential that the European Commission, the UK Government and UK research funders work with urgency to rebuild the strong position the UK occupied in the Horizon programme, and get funds and global collaboration flowing again into our research institutions.”
Dame Professor Angela McLean, Government Chief Scientific Adviser said: “This is great news for UK science and technology.
“International collaboration is a vital part of a thriving science ecosystem and association with the Horizon programme bolsters our plans to secure our status as a science and technology superpower.
Chief Executive of the Russell Group, Dr Tim Bradshaw said: “Association to Horizon Europe is tremendous news for UK science, research and innovation.
“We are delighted that a good deal has been struck, so all credit to the negotiating teams who have been working hard behind the scenes to get this over the line.
“This deal is a true win-win for everyone. The scale of research supported by Horizon Europe will help deliver medical breakthroughs, new technologies, and advances in areas such as AI to improve all our lives and help tackle the shared environmental, economic, and social challenges we face.
“The research community on both sides of the Channel are raring to go and will spare no effort in making our association a success. Universities have plans in place to get researchers to apply and our partner universities and businesses across the EU – and in other associated countries – are eager to work with our institutions.
“We will be ready to work with Government and the Commission to make the most of Horizon’s opportunities from day one and beyond into its successor.”
John Hanley, Chair of the UKspace trade body, said: “UKspace welcomes the news that the UK is reassociating with the EU Copernicus and Horizon Programmes.
“We have a strong track record within Copernicus with UK industry securing valuable contracts that have delivered jobs and growth across the country whilst unlocking a better understanding of our planet.
“We look forward to working with the Government to capitalise quickly on this agreement and identify the actions needed to build upon the UK’s national Earth Observation initiatives to ensure that industry can once more take a leading role in the largest multi-lateral EO Programme in the world.”
Grazia Vittadini, Chief Technology Officer for Rolls-Royce, said: “Horizon Europe has had a significant impact on Aerospace technologies and in helping Rolls-Royce remain at the forefront of technological advancement.
“We greatly welcome the UK’s return to the Horizon Europe programme, and look forward to going further and doing more, leveraging public-private partnership to continue driving world-leading innovation and competitiveness.
Dr Diana Beech, Chief Executive Officer, London Higher said: “The confirmation that the UK will rejoin Horizon Europe is welcome news for universities across London, the UK’s top ranked innovation cluster.
“The wait to associate to Horizon may have been lengthy but worthwhile, as today’s announcement shores up the future of research, innovation and higher education across the United Kingdom.
“With the assurance of association, London’s higher education and research community now has a renewed sense of purpose and optimism that London can reach its true potential as a research powerhouse.
“Association is both a recognition of the value we bring to the international scientific community and the acknowledgment that we are still very much a part of a global network of knowledge-sharing and innovation.
“Our universities now have the certainty and stability needed to continue powering the engine of UK innovation and to build connectivity across the regions as we seek to level up across the country and make the UK a global science superpower.
“We are committed to working collaboratively with our European partners, leveraging our collective expertise to drive innovation, support research excellence, and build a brighter future for all.”
Professor Paul Stewart FMedSci, Academy of Medical Sciences Vice President, Clinical, said: “Today marks a pivotal moment for UK science. After a hiatus, the scientific community is celebrating the tremendous news that we are once more part of the EU’s flagship funding programme.
“By associating to Horizon Europe, we now have the commitment and momentum to drive forward the Government’s vision for an innovative, high growth future and are well placed to support the diverse and highly skilled research talent that underpins our life sciences sector.
“Health research is an international endeavour, it relies on supporting the best ideas, but also on creating cross-border networks which is good news for the UK, Europe and the rest of the world. Association sends a very strong message that the UK is open for business and remains a prime destination to work on health research and innovation to improve lives.”
UKRI Chief Executive Professor Dame Ottoline Leyser said: “Today’s agreement on UK association to Horizon Europe is brilliant news.
“The UK has a long track record of mutually beneficial participation in previous EU schemes and this decision enables us to build on those highly successful collaborations to maximise the opportunities membership of Horizon Europe provides.
“UKRI is looking forward to working with our communities and partners to capture the many benefits of Horizon Europe for researchers and businesses.”
John Harrison, Chairman of Airbus UK: “It is great news that the U.K. will be rejoining Horizon Europe, which is a key funding programme for research and innovation, as well as the Copernicus programme.
“Having provided many of Copernicus’ critical technologies from the U.K., as well as designing and building the Sentinel 5P satellite in Stevenage, we look forward to contributing to future Copernicus Earth observation missions which play such a key role in understanding and tackling the planet’s changing climate.”
Dr Paul Bate, Chief Executive of the UK Space Agency, said: “The UK has a long history of expertise and innovation in Earth observation, so it is excellent news that we are going to continue our association in the EU part of Copernicus programme. This is a great outcome for our world-leading Earth observation sector, who we have worked closely with to support.
“Participating in Copernicus will enable the UK space sector to continue to play a significant role in the development of critical missions that will enable us to monitor our planet more effectively and lead a global effort through the use of satellite data to find new solutions to the urgent challenge of climate change.”
Ilan Gur, CEO of Advanced Research + Invention Agency: “A strong, interconnected scientific ecosystem is the foundation of breakthrough discovery and invention.
“This is wonderful news — a boost to science innovation not just for the UK but for the world!
A European mission to explore how gravity, dark energy and dark matter has shaped the Universe has launched following £37 million UK Space Agency funding.
The Euclid space telescope will map the “dark Universe” by observing billions of galaxies out to 10 billion lightyears, across more than a third of the sky, to gather data on how its structure has formed over its cosmic history.
Led by the European Space Agency (ESA) and a consortium of 2,000 scientists across 16 countries, Euclid will spend six years venturing through space with two scientific instruments: a UK-built visible imager (VIS) that will become one of the largest cameras ever sent into space, and a near infrared spectrometer and photometer, developed in France.
Secretary of State for Science and Technology Chloe Smith said: “The launch of the Euclid mission is a truly significant moment. Backed by £37 million in UK funding and supported by our remarkable scientific talent and expertise, the mission will launch one of the largest cameras ever into space to look out across our universe.
“The mission will gain unparalleled insight into the mysteries of how the Universe was formed, delivering ground-breaking discoveries that will redefine what we know about space.”
Dr Paul Bate, Chief Executive of the UK Space Agency, said: “Watching the launch of Euclid, I feel inspired by the years of hard work from thousands of people that go into space science missions, and the fundamental importance of discovery – how we set out to understand and explore the Universe.
“The UK Space Agency’s £37 million investment in Euclid has supported world-class science on this journey, from the development of the ground segment to the build of the crucial visible imager instrument, which will help humanity begin to uncover the mysteries of dark matter and dark energy.”
The Euclid spacecraft being loaded into the SpaceX Falcon 9 fairing ahead of launch, on 27 June 2023. Credit: SpaceX.
Euclid took off on board a SpaceX spacecraft from Cape Canaveral in Florida at 4.12pm (BST) on 1 July.
The UK Space Agency’s funding goes back to 2010, up to 2024, and is divided between teams at University College London, The Open University, University of Cambridge, University of Edinburgh, University of Oxford, University of Portsmouth and Durham University.
All these institutions have contributed to the development and implementation of the Euclid UK Science Ground Segment (UKSGS), which runs the Euclid data analysis. Led by the University of Edinburgh, which hosts Euclid’s UK Science Data Centre (SDC-UK), the UKSGS will process hundreds of petabytes of data over the next six years to produce maps of the galaxies and dark matter of the Universe.
The wider Euclid Consortium includes experts from 300 organisations across 13 European countries, the US, Canada and Japan.
The Science and Technology Facilities Council (STFC) also contributed to design and development work on Euclid instrumentation and provided funding to UK astronomy teams who will analyse the data returned from the mission, including studies on the physics responsible for the observed accelerated expansion of the Universe.
Executive Chair at STFC Professor Mark Thomson said: “Euclid will answer some of the biggest and most profound questions we have about the Universe and dark energy. Congratulations to everyone involved in the design, construction and launch of Euclid – we are opening a new window on the cosmos.
“This is a fantastic example of close collaboration between scientists, engineers, technicians, and astronomers across Europe working together to tackle some of the biggest questions in science.”
Research funded by the UK Space Agency
University College London (MSSL and P&A) – Design, build and testing of Euclid’s VIS optical camera (£20.5 million)
UCL researchers have led on designing, building and testing the VIS optical camera, one of Euclid’s two instruments, working with teams at Open University as well as in France, Italy and Switzerland.
The core electronics for the instrument, including its complex array of 36 CCDs (that convert photons into electrons), were built at UCL’s Mullard Space Science Laboratory.
The camera, one of the largest ever sent into space, will take high resolution, panoramic images of a large swathe of the Universe, going back 10 billion years and covering a third of the night sky.
Professor Benjamin Joachimi (UCL Physics & Astronomy) is also playing a key role in the ground-based part of the mission (the ground segment), converting Euclid’s raw data into statistical summaries that can be compared to our current theoretical models of the universe.
Professor Mark Cropper, leader of the VIS camera team at UCL Mullard Space Science Laboratory, said: “The VIS instrument will image a large swathe of the distant Universe with almost the fine resolution of the Hubble Space Telescope, observing more of the Universe in one day than Hubble did in 25 years.
“The data will allow us to infer the distribution of dark matter across the Universe more precisely than ever before. The galaxies being imaged are up to 10 billion years old so we will also see how dark matter has evolved over most of the Universe’s history. The Universe on this scale has not yet been seen in this level of detail.”
Professor Tom Kitching, one of four science co-ordinators for Euclid, said: “The puzzles we hope to address are fundamental. Are our models of the Universe correct?
“What is dark energy? Is it vacuum energy – the energy of virtual particles popping in and out of existence in empty space? Is it a new particle field that we didn’t expect? Or it may be Einstein’s theory of gravity that is wrong.
“Whatever the answer, a revolution in physics is almost guaranteed.”
University of Edinburgh (£8.9 million)
Edinburgh has been involved in the design and build of Euclid from its earliest days – leading the Euclid gravitational lensing data analysis, the UK Data Science Analysis and host to the UK’s Euclid Science Data Centre which will process hundreds of petabytes of data throughout the mission.
Professor Andy Taylor, leader of the gravitational lensing analysis for Euclid, the UK’s Euclid Science Data Analysis and SDC-UK, said: “This is a very exciting time for astronomy, and cosmology in particular.
“Euclid is designed to answer some of the biggest questions we have about the Universe. It has been a lot of hard work by many scientists to get here, but the results could change how we understand nature.
Professor Alkistis Pourtsidou, leader of Euclid’s nonlinear modelling team said: “Euclid is going to provide a very large and very detailed 3D map of the Universe, across the sky and along time.
“This map is a remarkable achievement combining state-of-the-art science and engineering. We want to extract the maximum amount of information from it and use it to figure out how nature works at the most fundamental level.
Dr Alex Hall, deputy leader of the gravitational lensing science working group, said: With the launch of Euclid begins an astronomical observing campaign that is amongst the most ambitious ever attempted.
“By imaging over a billion galaxies, Euclid will allow us to make a map of dark matter with unprecedented precision that will answer fundamental questions about our Universe. The next few years are going to be very exciting, and it is a privilege to be part of this incredible project.”
University of Oxford – Developing lensing signal measurement and correction for the effects of telescope and detectors on the data (£2.1 million)
Oxford’s Department of Physics has played a significant role in the lensing data analysis. As well as contributing to the development of the method used to measure the lensing signal, the team have specialised in correcting for the effects that the telescope and imaging detectors have on the data.
No telescope system is perfect – there is always some blurring and distortion of the images – and Oxford’s role has been not only to build the software models but also to devise ways of calibrating those models using dedicated in-orbit data from Euclid. These are crucial steps that allow the lensing measurements to be used to explore the dark side of our Universe.
Professor Lance Miller, leader of the work at the University of Oxford, said: “This is an incredibly exciting time.
“This space mission is the result of years of work and for us here in Oxford, that work continues as we put the finishing touches to the software that will be analysing some of the first Euclid data sent back to Earth, from August onwards.
“I have been working on Euclid since its inception, so to have reached this major milestone today is extraordinary. It is fantastic to be part of a mission that could play a fundamental role in our understanding of the Universe.
University of Portsmouth – Writing code for data analysis (£1.8 million)
The University of Portsmouth’s team, led by Ernest Rutherford Fellow, Dr Seshadri Nadathur, has been working with the wider European team, writing code that will help analyse data from the spacecraft.
Dr Seshadri Nadathur, from Portsmouth’s Institute of Cosmology and Gravitation, said: “Galaxies are not randomly scattered around the sky – instead there are patterns in their positions that are relics of correlations created at the time of the Big Bang, shaped over billions of years by the interplay of gravity pulling galaxies together and the expansion of the Universe driving them apart.
“By measuring and understanding these patterns in the maps Euclid will provide, we will learn about the mysterious force of dark energy that seems to be driving the Universe to expand ever faster.
“The team at Portsmouth has been busy developing and testing software that builds the maps and allows them to correct for any spurious patterns in the galaxy positions that arise purely due to variations in the performance of the telescope and instruments, so that we can isolate the true cosmological patterns we are interested in.”
Durham University – Building Euclid tolerance to radiation and supercomputer mock data (£1.3 million)
Professor Richard Massey, of Durham University’s Centre for Extragalactic Astronomy/Institute for Computational Cosmology, is a founder of the Euclid mission and has been developing its design and science goals for 20 years.
Work from a team of international researchers has included making Euclid’s camera more tolerant to the high radiation environment in which it will need to survive above the Earth’s atmosphere, learning from our experience with the Hubble Space Telescope.
As well as leading on Euclid’s radiation monitoring and mitigation strategy, Durham has used supercomputer simulation capabilities to create mock data to train Euclid’s analysis software, which will be compared against the spacecraft’s real observations.
Professor Richard Massey said: “When exploring any wild new frontier, the first step is to map the land. Euclid will make the largest ever map (with a tiny ‘you are here’ at the centre) and will show the invisible Universe.
“By revealing where dark matter and dark energy hide, we hope to take the second step – to discover what they are and trigger a gold rush of new science about how they behave.
“Euclid is like the Hubble Space Telescope, but with a wide-angle view. It will let astronomers stand back and see the sweeping vista of the Universe – but with the same high-resolution detail.
“Exploring and mapping new frontiers is the most human thing possible. Helping shape our next look into the dark has been a privilege.
“It has taken 20 years to make Euclid’s technology possible, engineer its details, and navigate the politics of competing against other proposed missions that would all discover amazing things. That rocket carries the sense of exploration and lifetimes’ work of thousands of scientists and engineers.”
The Open University – Developing and testing VIS detectors (£1.2 million)
The Open University’s Centre for Electronic Imaging (CEI) has been involved in developing the detectors for the VIS instrument and testing how they will perform in the harsh radiation environment in space.
The team will continue to monitor the detectors during the mission, to help mitigate the effects of the damage caused by high energy particles outside the Earth’s protective atmosphere, allowing Euclid to return the best possible science for the mission lifetime.
Dr Jesper Skottfelt, CEI Fellow at The Open University, said: “After 15 years of CEI involvement in the Euclid mission, it is exciting to see the spacecraft being launched.
“Our study of the VIS detectors has led to the development of new techniques to correct the effects of radiation damage which will enhance science return for this and future space missions.
“We look forward to seeing the progress Euclid will deliver towards answering some of the most fundamental questions we have about our Universe.
University of Cambridge – Developing astrometric calibration pipeline for Euclid image data (£870,000)
The University of Cambridge’s Institute of Astronomy (IoA) team has been involved in Euclid since 2010, supporting development of the astrometric calibration pipeline for the optical image data from Euclid, ensuring that the positions of the billions of sources to be imaged by Euclid can be determined to exquisite accuracy.
Nicholas Walton, leader of the IoA Euclid team and a Director of Research at the University of Cambridge, said: Dark energy and dark matter fundamentally govern the formation and evolution of our Universe.
“The Euclid mission will finally uncover the mysteries of how these ‘dark’ forces have shaped the cosmos that we see today, from life here on Earth, to our Sun, our Milky Way, our nearby galaxy neighbours, and the wider Universe beyond.”
MEDICAL RESEARCH SCOTLAND INSPIRES OVER 1,400 YOUNG PEOPLE WITH LIVE-STREAMED EVENTS
Medical Research Scotland, Scotland’s largest independent medical research charity, has helped over 1,400 young people across Scotland connect with the country’s leading scientists and academics to learn about further education and careers in medical science.
The Medical Research Scotland virtual academy has had a significant impact on the education and career prospects of pupils across Scotland. With participation from over 1,400 students from 36 schools spanning from Aberdeen to the Scottish Borders, the academy has successfully engaged students with an interest in STEM subjects. The primary goal for the academy is to address the shortage of STEM skills in Scotland by providing students with interactive experience and exposure to medical research.
S4, S5 & S6 pupils from schools across Scotland joined each Friday morning for a month of live streamed weekly interactive lessons, which were broadcasted straight to their science classrooms, allowing pupils to watch from the comfort of their own learning environments. Throughout the course, students were treated to a range of inspiring and insightful presentations from scientists, lecturers, and PhD students whose studies were funded by Medical Research Scotland.
The academy is a free tool that was delivered virtually and is also available to be streamed on demand making it a versatile resource that can be utilised throughout teaching schedules.
One school that benefitted from the Medical Research Scotland Academy virtual webinar series was James Gillespie’s High School in Edinburgh.
Pupils here gained the opportunity to learn about medical research into viruses, pharmaceuticals, how medical research was an integral part of combatting the global pandemic and much more from previous and present PhD students from the University of St Andrews, University of Aberdeen, Heriot-Watt University and the University of Dundee.
Iain Coltart, Head of Science at James Gillespie’s High School, said: “I am thrilled to see the incredible impact of the Medical Research Scotland Academy on our pupils.
“Through this programme, our students have gained invaluable insights into cutting-edge medical research, engaging with leading experts in the field and deepening their understanding of scientific concepts.
“The learning experience and exposure to real-world medical research has ignited their passion for science. We are grateful for this unique opportunity that has empowered our students and inspired them to pursue careers in the field of medical research.”
Professor Heather Wallace, Chair of Medical Research Scotland, said:“As Chair of Medical Research Scotland, I take pride in Scotland’s rich heritage of producing world-class research scientists who have made ground-breaking discoveries and contributed to global health advancements.
“The goal of the Medical Research Scotland Academy is to inspire and foster connections between the next generation of aspiring medical professionals and valued academics in Scotland. We have witnessed the immense enthusiasm for medical science among school leavers from various schools across the country, and it is truly gratifying to see.”
Medical Research Scotland is dedicated to advancing health in Scotland and beyond through the support of cutting-edge research aimed at enhancing the diagnosis, treatment, and prevention of diseases.
To join us in our mission, please visit our website at:
